Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Prolonged prophylaxis after joint replacement: another step sideways?

    Davidson BL, Lensing AW.

    Ann Intern Med. 2000 Jun 6;132(11):914-5. No abstract available. PMID: 10836920 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.

    Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J.

    Ann Intern Med. 2000 Jun 6;132(11):853-61.PMID: 10836911 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.

    Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA.

    Arch Intern Med. 2002 Jul 8;162(13):1465-71.PMID: 12090882 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group.

    Int Angiol. 2006 Dec;25(4):335-42.PMID: 17164738 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.

    Friedman RJ.

    J Am Acad Orthop Surg. 2007 Mar;15(3):148-55. Review.PMID: 17341671 [PubMed - indexed for MEDLINE]Related articles

    7.

    A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.

    Abad JI, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin 6 Hours After Surgery Study Group.

    Arch Orthop Trauma Surg. 2007 Oct;127(8):665-70. Epub 2006 Nov 7.PMID: 17089172 [PubMed - indexed for MEDLINE]Related articles

    8.

    Extended thromboprophylaxis after hip or knee replacement.

    Friedman RJ.

    Orthopedics. 2003 Feb;26(2 Suppl):s225-30. Review.PMID: 12597230 [PubMed - indexed for MEDLINE]Related articles

    9.

    Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.

    Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT.

    J Bone Joint Surg Am. 2007 Dec;89(12):2648-57.PMID: 18056497 [PubMed - indexed for MEDLINE]Related articles

    10.
    11.

    [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?]

    Nielsen JD.

    Ugeskr Laeger. 2005 May 23;167(21):2261-5. Review. Danish. No abstract available. PMID: 15962850 [PubMed - indexed for MEDLINE]Related articles

    12.

    Low molecular weight heparin for the prevention and treatment of venous thromboembolism.

    Raskob GE.

    Curr Opin Pulm Med. 1996 Jul;2(4):305-10. Review.PMID: 9363157 [PubMed - indexed for MEDLINE]Related articles

    13.

    Venous thromboembolism debate in joint arthroplasty.

    Lieberman JR, Barnes CL, Lachiewicz PF, Hanssen AD, Clarke HD, Pellegrini VD Jr.

    J Bone Joint Surg Am. 2009 Aug;91 Suppl 5:29-32. No abstract available. PMID: 19648620 [PubMed - indexed for MEDLINE]Related articles

    14.

    The risk of venous thromboembolism in non-large-joint surgeries.

    Muntz JE.

    Orthopedics. 2003 Feb;26(2 Suppl):s237-42. Review.PMID: 12597232 [PubMed - indexed for MEDLINE]Related articles

    15.

    Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.

    Eikelboom JW, Quinlan DJ, Douketis JD.

    Lancet. 2001 Jul 7;358(9275):9-15.PMID: 11454370 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prevention of venous thromboembolism.

    Geerts W, Ray JG, Colwell CW, Bergqvist D, Pineo GF, Lassen MR, Heit JA.

    Chest. 2005 Nov;128(5):3775-6. No abstract available. PMID: 16304350 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Is low-molecular-weight heparin suitable in all patients undergoing knee arthroplasty?

    Geerts W.

    Ann Intern Med. 2008 Nov 4;149(9):687; author reply 687-8. No abstract available. PMID: 18981493 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery.

    Heit JA.

    Arch Intern Med. 2002 Sep 9;162(16):1806-8. No abstract available. PMID: 12196077 [PubMed - indexed for MEDLINE]Related articles

    19.

    Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.

    Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators.

    Arch Intern Med. 2002 Oct 28;162(19):2191-6.PMID: 12390061 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.

    Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.

    Anesthesiology. 2003 Sep;99(3):552-60; discussion 5A.PMID: 12960538 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data